You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ESA intolerant

Showing 51 - 75 of 628
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)

Completed
  • Candidiasis, Chronic Mucocutaneous
  • Amphotericin B
  • Bethesda, Maryland
    National Institute of Allergy and Infectious Disease (NIAID)
Aug 17, 2022

Anemia Associated With Chronic Kidney Disease Trial in Hangzhou (Roxadustat)

Recruiting
  • Anemia Associated With Chronic Kidney Disease
  • Hangzhou, Zhejiang, China
    Children's Hospital, Zhejiang University School of Medicine
Aug 5, 2021

Chronic Atrial Fibrillation Trial in Clearwater, Atlanta, Baltimore (Epicardial And Endocardial RF Ablation For The Treatment Of

Recruiting
  • Chronic Atrial Fibrillation
  • Epicardial And Endocardial RF Ablation For The Treatment Of Symptomatic Long-standing Persistent AF
  • Newport Beach, California
  • +4 more
Dec 14, 2022

Solid Tumor Trial (IN10018, Nab-paclitaxel, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Aug 1, 2023

Studies at Clinic for Anesthesiology and Intensive Care Medicine

Recruiting
  • Delirium
    • Berlin, Germany
      Department of Anaesthesiolgy and Intensive Care Medicine CVK/CCM
    Jun 12, 2023

    Penpulimab in Maintenance Therapy in Lymphoma

    Not yet recruiting
    • Lymphoma
    • (no location specified)
    Dec 25, 2022

    Polycythemia Vera Trial in Worldwide (Idasanutlin)

    Terminated
    Has Results
    • Polycythemia Vera
    • Phoenix, Arizona
    • +10 more
    Dec 7, 2021

    Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

    Recruiting
    • Myelofibrosis
    • +3 more
    • Birmingham, Alabama
    • +36 more
    May 5, 2022

    CDKL5 Disorder Trial (Ganaxolone)

    Available
    • CDKL5 Disorder
    • (no location specified)
    Apr 1, 2022

    Chronic Myeloid Leukemia Trial in Worldwide (ELVN-001)

    Recruiting
    • Chronic Myeloid Leukemia
    • New York, New York
    • +22 more
    Aug 15, 2022

    Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

    Not yet recruiting
    • Leukemia
    • +4 more
    • (no location specified)
    Jul 27, 2022

    MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

    Recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Luspatercept Injection [Reblozyl]
    • Alessandria, Italy
    • +22 more
    Jun 20, 2023

    Multiple Myeloma Trial in Worldwide (RO7425781)

    Recruiting
    • Multiple Myeloma
    • North Melbourne, Victoria, Australia
    • +15 more
    Jan 19, 2023

    Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    • Boston, Massachusetts
    • +18 more
    Jan 19, 2023

    Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

    Recruiting
    • Chronic Myelogenous Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 27, 2022

    Meibomian Gland Dysfunction, Dry Eye Syndromes, Ocular Surface Disease Trial in San Antonio (Zocular Eyelid System Treatment)

    Completed
    • Meibomian Gland Dysfunction
    • +2 more
    • Zocular Eyelid System Treatment
    • San Antonio, Texas
      Rosenberg School of Optometry
    Jul 13, 2022

    Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

    Recruiting
    • Colorectal Cancer
    • Omaha, Nebraska
      Exelixis Clinical Site #1
    Jul 26, 2022

    Myelofibrosis Trial in Worldwide (TL-895)

    Recruiting
    • Myelofibrosis
    • Aurora, Colorado
    • +65 more
    Jun 2, 2022

    Assess the Safety of Fedratinib in Korean Myelofibrosis

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Leukemia Trial in Worldwide (Dasatinib)

    Active, not recruiting
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +173 more
    Dec 1, 2022

    Solid Tumors Trial in United States (RAIN-32)

    Recruiting
    • Solid Tumors
    • Palo Alto, California
    • +9 more
    Aug 16, 2022

    Low Risk MDS Trial (R906289 Monosodium (R289 Na))

    Not yet recruiting
    • Low Risk Myelodysplastic Syndromes
    • R906289 Monosodium (R289 Na)
    • (no location specified)
    Jul 22, 2022

    Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)

    Active, not recruiting
    Has Results
    • Atopic Dermatitis
    • Graz, Steiermark, Austria
    • +102 more
    May 25, 2022

    Advanced Solid Tumors Trial in Worldwide (Olaparib)

    Recruiting
    • Advanced Solid Neoplasms
    • Tucson, Arizona
    • +128 more
    Aug 18, 2022

    Persistent Atrial Fibrillation Trial in United Kingdom, United States (AtriCure EPi-Sense-AF Guided Coagulation System with

    Active, not recruiting
    Has Results
    • Persistent Atrial Fibrillation
    • AtriCure EPi-Sense-AF Guided Coagulation System with VisiTrax
    • Endocardial RF Catheter ablation using Open Irrigated-tip RF Abaltion Catheter with unidirectional or bidirectional steering
    • Birmingham, Alabama
    • +26 more
    Jun 20, 2022